CTI BioPharma Statistics
Total Valuation
CRT has a market cap or net worth of $53.67 million. The enterprise value is $51.73 million.
Important Dates
| Earnings Date | n/a |
| Ex-Dividend Date | Jul 31, 2025 |
Share Statistics
CRT has 6.00 million shares outstanding.
| Current Share Class | 6.00M |
| Shares Outstanding | 6.00M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | 2.92% |
| Float | n/a |
Valuation Ratios
The trailing PE ratio is 8.99.
| PE Ratio | 8.99 |
| Forward PE | n/a |
| PS Ratio | 7.85 |
| Forward PS | n/a |
| PB Ratio | 22.87 |
| P/TBV Ratio | 22.87 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | 8.67 |
| EV / Sales | 7.57 |
| EV / EBITDA | n/a |
| EV / EBIT | 8.67 |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.00
| Current Ratio | 1.00 |
| Quick Ratio | 1.00 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 240.32% and return on invested capital (ROIC) is 150.20%.
| Return on Equity (ROE) | 240.32% |
| Return on Assets (ROA) | 92.98% |
| Return on Invested Capital (ROIC) | 150.20% |
| Return on Capital Employed (ROCE) | 254.34% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 1.70 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -13.49% in the last 52 weeks. The beta is 0.13, so CRT's price volatility has been lower than the market average.
| Beta (5Y) | 0.13 |
| 52-Week Price Change | -13.49% |
| 50-Day Moving Average | 9.78 |
| 200-Day Moving Average | 10.34 |
| Relative Strength Index (RSI) | 23.96 |
| Average Volume (20 Days) | 21,313 |
Short Selling Information
The latest short interest is 7,862, so 0.13% of the outstanding shares have been sold short.
| Short Interest | 7,862 |
| Short Previous Month | 2,284 |
| Short % of Shares Out | 0.13% |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 0.40 |
Income Statement
In the last 12 months, CRT had revenue of $6.83 million and earned $5.97 million in profits. Earnings per share was $0.99.
| Revenue | 6.83M |
| Gross Profit | 6.83M |
| Operating Income | 5.97M |
| Pretax Income | 9.40M |
| Net Income | 5.97M |
| EBITDA | n/a |
| EBIT | 5.97M |
| Earnings Per Share (EPS) | $0.99 |
Full Income StatementBalance Sheet
The company has $1.94 million in cash and n/a in debt, giving a net cash position of $1.94 million or $0.32 per share.
| Cash & Cash Equivalents | 1.94M |
| Total Debt | n/a |
| Net Cash | 1.94M |
| Net Cash Per Share | $0.32 |
| Equity (Book Value) | 2.35M |
| Book Value Per Share | 0.39 |
| Working Capital | n/a |
Full Balance SheetMargins
Gross margin is 100.00%, with operating and profit margins of 87.33% and 87.33%.
| Gross Margin | 100.00% |
| Operating Margin | 87.33% |
| Pretax Margin | 87.33% |
| Profit Margin | 87.33% |
| EBITDA Margin | n/a |
| EBIT Margin | 87.33% |
| FCF Margin | n/a |
